Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 07:50 am Unchanged | 2023-12-31 | 13G | Constellation Acquisition Corp I CSTAF | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-07 07:50 am Purchase | 2023-12-31 | 13G | Mammoth Energy Services, Inc. TUSK | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,275,000 8.920% | 1,147,732 (+36.70%) | Filing History |
| 2024-02-07 07:46 am Sale | 2023-12-31 | 13G | ESGEN Acquisition Corporation ESAC | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -1,620,000 (Position Closed) | Filing History |
| 2024-02-07 07:46 am Purchase | 2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | ADAGE CAPITAL PARTNERS GP L.L.C. | 738,666 8.400% | 738,666 (New Position) | Filing History |
| 2024-02-07 07:46 am Purchase | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,537,500 8.970% | 2,437,362 (+78.62%) | Filing History |
| 2024-02-07 07:45 am Sale | 2023-12-31 | 13G | TScan Therapeutics, Inc. TCRX | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,900,000 8.960% | -100,000 (-2.50%) | Filing History |
| 2024-02-07 07:45 am Sale | 2023-12-31 | 13G | Rain Enhancement Technologies Holdco Inc RAIN | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -1,523,282 (Position Closed) | Filing History |
| 2024-02-07 07:44 am Sale | 2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,506,422 2.440% | -1,964,125 (-56.59%) | Filing History |
| 2024-02-07 07:43 am Sale | 2023-12-31 | 13G | Adams Natural Resources Fund, Inc. PEO | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -1,308,791 (Position Closed) | Filing History |
| 2024-02-07 07:43 am Sale | 2023-12-31 | 13G | Finance Of America Companies Inc. FOA | ADAGE CAPITAL PARTNERS GP L.L.C. | 334,288 3.800% | -19,592 (-5.54%) | Filing History |
| 2024-02-07 07:43 am Unchanged | 2023-12-31 | 13G | Power & Digital Infrastructure Acquisition II Corp. XPDB | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-07 07:42 am Sale | 2023-12-31 | 13G | Sitio Royalties Corp. STR | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,947,589 4.830% | -155,246 (-3.78%) | Filing History |
| 2024-02-07 07:42 am Sale | 2023-12-31 | 13G | INDEPENDENCE CONTRACT DRILLING ICDIQ | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -710,757 (Position Closed) | Filing History |
| 2024-02-07 07:41 am Sale | 2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,291,701 2.240% | -1,663,299 (-56.29%) | Filing History |
| 2024-02-07 07:40 am Sale | 2023-12-31 | 13G | Catcha Investment Corp CHAA | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -1,600,000 (Position Closed) | Filing History |
| 2024-02-07 07:40 am Sale | 2023-12-31 | 13G | 9 Meters Biopharma, Inc. NMTRQ | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -650,000 (Position Closed) | Filing History |
| 2024-02-07 07:39 am Sale | 2023-12-31 | 13G | NPK International Inc. NPKI | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,234,953 1.450% | -4,778,698 (-79.46%) | Filing History |
| 2024-02-07 07:39 am Sale | 2023-12-31 | 13G | Talos Energy Inc. TALO | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,805,360 2.260% | -3,607,138 (-56.25%) | Filing History |
| 2024-02-07 07:38 am Sale | 2023-12-31 | 13G | Vinci Partners Investments Ltd. VINP | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,011,610 5.100% | -1,150,271 (-36.38%) | Filing History |
| 2024-02-07 07:37 am Sale | 2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 500,000 0.670% | -3,918,962 (-88.69%) | Filing History |